Delivery Order SPE2DB22D2214-SPE2DB24FS4MN
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $1.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of TLANDO 112.5 MG CAPSULE 120S to the Defense Logistics Agency (DLA). The contract, valued at $1,516.83, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of March 20, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of TLANDO 112.5 MG CAPSULE 120S to the Defense Logistics Agency (DLA), a defense agency. The $2,997.95 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025 with a completion date of July 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is for the delivery of TLANDO 112.5 MG CAPSULE 120S, a medical product. The contract has a firm fixed price of $1,011.22 and an ultimate completion date of June 5, 2025. The award was made on June 4, 2025, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,374.91, is for the delivery of TLANDO 112.5 MG CAPSULE 120S, a pharmaceutical product, with a completion date of February 29, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,729.49, is for the delivery of 120 units of the drug TLANDO 112.5 MG CAPSULE. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a...
- The Defense Logistics Agency issued a delivery order valued at $2,217.60 to AmerisourceBergen Drug Corp for TLANDO 112.5 mg capsules (120-count units) on September 19, 2025, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed price delivery order was issued under a non-set-aside procurement and represents a continuation of the government's ongoing pharmaceutical supply chain management through AmerisourceBergen's established contract vehicles. This delivery...
- This federal contract award, valued at $1,185.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,460.19 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 29, 2024. The contract was awarded under the DLA's Troop Support Medical Indefinite Delivery Contract, a large medical commodities vehicle valued up to $999,999,999 through December 2025,...
- This federal contract award is for a delivery order with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply LINZESS 290 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA). The $3,201.81 firm fixed price contract has a completion date of July 18, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. The contract is part of Amerisourcebergen's substantial Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,315.14 Firm Fixed Price delivery order is for the supply of LINZESS 290 MCG capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which serves as the primary vehicle for the company to provide a range of pharmaceutical products and...